“…Several compounds have been selected recently as inhibitors of the in vitro multiplication of rhinoviruses, namely guanidine [20], HBB and other benzimidazoles [9,18,20], a thiosemicarbazone derivative [8], 3-substituted triazinoindoles [3,8,10,11,14,15,21], some pyrimidine analogues [12,13,19], 4'-hydroxy-5,6,7,8-tetramethoxyflavone [4], and aromatic sulfonic acids [2]. Of all substances studied only some triazi-noindoles were active in vivo, in rhinovirus infections in primates [3,15] but not in humans [21].…”